Evaluation of Outcomes From Treatment of Benign or Malignant Gastroesophageal Diseases | MicrobiomeTrials← Back to trialsNCT04637256
Evaluation of Outcomes From Treatment of Benign or Malignant Gastroesophageal Diseases
CompletedOBSERVATIONAL
Trial Details
Start: 2019-03-06Est. Completion: 2021-02-27
Enrollment target: 500 participants Locations- Trinity Surgical Consultants, Methodist Richardson Medical Center, Richardson, Texas, United States
Other microbiome trials you might be interested in
Pancreatic Neuroendocrine Tumor (pNET)Extra-Pancreatic Neuroendocrine Tumor (epNET)
The primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants…
Birmingham, United StatesEst. completion Jun 30, 2029
Intraductal Papillary Mucinous Neoplasm of PancreasPancreatic Neoplasms
This prospective pilot study will evaluate the diagnostic performance of a previously validated artificial intelligence …
Guayaquil, EcuadorEst. completion May 30, 2027
HCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)Gastric CarcinomaBreast CancerLung CancerEndometrial CancerMelanoma (Skin Cancer)Pancreatic Cancer
This Vietnam-based observational study examines ecto-nucleotide pyrophosphatase/phosphodiesterase 1/cyclic GMP-AMP synth…
Hanoi, VietnamEst. completion Jun 30, 2027